SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (4586)6/29/1998 12:13:00 PM
From: Izzy  Read Replies (3) of 6136
 
Rick, are you suggesting that there are data indicating that there is a combo treatment regimen, without using a protease inhibitor, that show equal/better clinical/chemical (lab) results as those treatment regimens using a PI? And at what stage in the HIV disease process? If Remune is used in a treatment regimen, I would think that the use of a PI is imperative. Please educate me...Thanks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext